Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
Funded at University of Louisiana at Lafayette · NIH-10381439 · Data updated 2026-11-12
This study is looking at how well potential HIV vaccines work by using Rhesus macaques, which helps researchers learn more about preventing and controlling the virus, ultimately aiming to find better ways to protect people from HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2021 |
| Award (this year) | $1,656,214 |
| NIH project number | 75N93020D00008-P00001-759302000004-1 |
| Project ID | NIH-10381439 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of HIV infection who may benefit from advancements in vaccine development.
✕Less likely to help
Patients who are already living with HIV or those who do not have a risk of exposure to the virus may not receive direct benefits from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines for HIV/AIDS. It involves maintaining a breeding colony of Rhesus macaques to provide the necessary animal models for testing vaccine efficacy and immune responses. The program aims to support researchers in understanding how vaccines can prevent or control viral infections, ultimately leading to effective HIV prevention strategies. By conducting thorough evaluations, the research seeks to identify correlates of reduced risk of HIV acquisition.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is a well-established method in the field.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.